echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Bite! Super complete gout diagnosis and treatment strategy, please check!

    Bite! Super complete gout diagnosis and treatment strategy, please check!

    • Last Update: 2023-01-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    *For medical professionals only



    It's really full of dry goods~




    Gout is a crystal-associated arthropathy caused by monosodium urate (MSU) deposition in the joints and is directly associated with
    hyperuricemia (HUA) due to disturbance of purine metabolism and/or decreased uric acid excretion.
    As early as the 5th century BC, Hippocrates recorded the clinical manifestations of gout
    .
    The word gout is derived from the Latin Guta (a drop), which means a drop of harmful liquid that causes joint damage, and the pain is like a gust of wind, coming and going quickly, hence the name gout
    .
    Gout can be complicated by renal lesions, and in severe cases, joint destruction and renal function damage may occur, often accompanied by hyperlipidemia, hypertension, diabetes, arteriosclerosis and coronary heart disease
    .
    The huge number of sick people and the trend of younger diseases have caused a heavy burden
    on families and society.
    The "Medical Rheumatology and Immunology Channel" invited Professor Zhu Xiaoxia from the Department of Rheumatology and Immunology of Huashan Hospital affiliated to Fudan University to share with us those things
    about gout.


    Gout "son preference"? It's true!


    At present, the prevalence of gout in China is 1%~3%, and the stage data of the National Rheumatology Data Center (CRDC) network registration and follow-up research show that gout attacks are 15:1 for males: females, why are gout attacks so "son-preferred", is it really accidental? Professor Zhu Xiaoxia explained that Huashan Hospital and the Chinese Center for Disease Control and Prevention (CDC) cooperated with the Chinese Center for Disease Control and Prevention (CDC) to study the epidemiology of HUA, and found that the prevalence of HUA in men was significantly higher than that in women, 24.
    5% and 3.
    6%, respectively, especially the prevalence of young men aged 18 to 29 years was close to 33%, such a significant difference was mainly caused by the following aspects:
    • Men consume more: Men's daily diet intake of high-purine foods such as seafood, animal offal, and red meat is significantly higher
      than that of women.

    • Male metabolism is higher than female metabolism: 80% of uric acid in the human body comes from its own endogenous metabolism, and only 20% is exogenously ingested
      .
      Male muscles are much more developed than women, and muscle cell metabolism can produce a lot of uric acid, so men's blood uric acid will be higher
      than women's.
      Outpatient clinics will also find that the blood uric acid levels of some male fitness fanatics are significantly higher than others, which is also reasonable
      .

    • Protective effect of female estrogen: estrogen is a protective endogenous hormone that can promote the excretion of uric acid by the kidneys, so the blood uric acid level of women of childbearing age is relatively low, especially around 20
      years old.
      However, after menopause, a woman's blood uric acid level gradually increases
      .


    According to the above, the high prevalence of gout in men is due to several factors
    .


    3 major auxiliary examinations, each with its own advantages and disadvantages

    We know that at present, in addition to routine laboratory tests, blood uric acid determination, uric acid determination, imaging examination is also very important, and there are three commonly used imaging tests in clinical practice: 1, X-rays: X-ray film can be seen that the subchondral bone destruction caused by MSU crystal deposition is manifested as eccentric round or oval cystic changes, and even insect-like and piercing defects, and the edge of the bone defect can be "hanging edge sign"
    .
    In the late stage, the joint space may be significantly narrowed or even disappeared, forming fibrotonic rigidity, joint subluxation or dislocation, and even pathological fractures
    .
    X-rays of patients with early gout showing soft tissue edema or local inflammation have limited
    diagnostic value.
    When bone destruction occurs in middle or late gout, it is often irreversible
    .
    2.
    Dual-energy CT: Dual-energy CT is different from ordinary CT, dual-energy CT can accurately distinguish different tissue components in joint anatomy, display different colors, and can display MSU deposition
    in three-dimensional and three-dimensional MAG.
    Dual-energy CT examination is rapid and non-invasive, can detect early MSU deposition without clinical symptoms, and has strong objectivity, which is very helpful for diagnosis
    .
    At the same time, joint bone destruction or other damaging lesions
    can also be evaluated.
    The disadvantage is that the price is more expensive, there is a certain amount of radiation, and many hospitals do not currently carry out this examination, which causes certain inconvenience
    to patients.
    3.
    Joint
    ultrasound: synovial hyperplasia, joint inflammation, and bone and cartilage morphology and other joint and surrounding tissue lesions can be evaluated
    by ultrasound examination.
    Ultrasound features such as tophi, double-track sign, aggregate, and snowstorm sign are specific manifestations
    of musculoskeletal ultrasound for the diagnosis of gouty arthritis.
    In addition, ultrasound can clearly show the surface of the bone cortex to observe whether there is bone erosion; Ultrasound synovial inflammation and hyperplasia of the joint cavity has a high value in evaluating the severity of inflammation, and the blood flow signal is observed by energy Doppler to determine the severity
    of inflammation.
    In addition, it has the advantages
    of economy, convenience and no radiation.
    However, the disadvantage is that it cannot detect small bone destruction, and because ultrasound is a human-evaluated examination operation, the detection results depend on the level of the operator, there may be certain errors, and the operator cannot detect the part that the probe cannot reach during the operation, so it is difficult to make a comprehensive assessment
    .




    3 tips to control acute attacks of gout

    The treatment of gout has always been a topic of concern for everyone, and the current first-line drugs for the treatment of acute attacks of gout are colchicine, NSAIDs and glucocorticoids, and Professor Zhu Xiaoxia explained in detail some of the problems
    that need to be paid attention to in the process of medication.

    1.
    Colchicine

    • It can inhibit neutrophil chemotaxis to the joint, and early use of colchicine is recommended, especially before 36 hours, preferably within
      12 hours.
      Because
      after 36 hours, the inflammation has reached its peak and neutrophils have chemoted to the joints, then the effect of colchicine will not be able to exert its extreme
      .

    • The instructions will also deceive: at present, the instructions for colchicine are still the usual amount for adults to take 0.
      5~1mg orally every 1~2 hours, until the joint symptoms are relieved, or diarrhea or vomiting occurs, and the therapeutic amount is generally 3-5mg, and
      it should not exceed 6mg
      within 24 hours.
      Studies have shown that
      there is no significant difference between small doses and toxic doses of colchicine in the treatment of gout, and high-dose application of colchicine may have bone marrow suppression, liver and kidney insufficiency in addition to gastrointestinal adverse reactions such as diarrhea and vomiting
      .
      Why hasn't the manual been amended in this case? It is because the indications for modifying the instructions must be supported by
      RCT studies, but there are no RCT studies yet, so the instructions have not been modified, so patients will still use according to the instructions, which is currently a more contradictory point
      .

    • Colchicine correct opening method: it is recommended to add 0.
      5mg after 1 hour
      , change to 0.
      5mg after 12h, 1-3 times a day, depending on the condition and liver and kidney function

      .
      If the effect is not good, and then switch to other drugs, it is not recommended to increase the dose of colchicine, so the use of colchicine still needs to be cautious
      .

    • Renal insufficiency: In patients with renal insufficiency, it is necessary to reduce the dose as appropriate, and calculate the dose
      according to the renal function index.
      eGFR
      should be reduced at 30~50ml/min, and eGFR should be disabled when < 30ml/min<b30>.


    2.
    Non-steroidal anti-inflammatory drugs (NSAIDs)

    NSAIDs are widely used in China, but the controllability of use is not good, because there are too many NSAIDs on the market, and patients often struggle with which one
    to use.
    The general principle is to use rapid-acting formulations as early as possible and in full doses.

    However, it should be used
    with caution in patients with old age, liver and kidney insufficiency, hypertension, previous peptic ulcer, bleeding, and perforation.

    3.
    Glucocorticoids

    In the past, hormones were used as second-line drugs, and in recent years, guidelines have proposed hormones as first-line drugs
    .
    Because the study found that the analgesic effect of glucocorticoids in the acute attack of gout is similar to that
    of NSAIDs, but for patients with abnormal liver and kidney function, the use of the above two drugs is limited
    .
    Although there are also certain adverse reactions, such as hyperglycemia, hypertension, infection, etc.
    , for patients with chronic renal insufficiency, the safety of using hormones is better
    .




    Kidney damage + gout, medication should be vigilant

    Renal impairment is the second most common comorbid condition of hyperuricemia and gout, what should patients with gout and kidney disease pay attention to when undergoing uric acid-lowering therapy? Professor Zhu Xiaoxia emphasized that because renal insufficiency can cause a decrease in blood uric acid excretion, resulting in an increase
    in blood uric acid.
    Conversely, if blood uric acid is elevated for a long time, it can also cause acute or chronic renal impairment
    .
    Therefore, when renal insufficiency and gout are found, it is first necessary to judge the causal relationship, clarify the cause of renal function damage as soon as possible, and then reverse or restore kidney function as much as possible, which is the most basic principle
    .
    On top of this principle, we choose uric acid-lowering drugs
    .
    • Allopurinol and febuxostat: in patients with renal insufficiency, drugs that inhibit uric acid production are allopurinol or febuxostat.

      It should be noted that in addition to monitoring routine adverse reactions, the occurrence of allopurinol hypersensitivity reaction is significantly correlated with HLA-B*5801 positivity, and the frequency of carrying this genotype in Han people is 10%~20%, so domestic and foreign guidelines are on HLA-B*5801 Allopurinol is not recommended in positive patients, and HLA-B*5801 is best tested before taking allopurinol for the first time in areas where conditions permit.

      In patients with renal insufficiency,
      the dose
      of allopurinol can be adjusted according to eGFR.
      When the eGFR is 15~60ml/min (equivalent to CKD stage 3~4), the amount of allopurinol should be reduced; When eGFR < 15 ml/min (equivalent to CKD stage 5), allopurinol should be disabled<b22>.
      In patients with moderate to severe renal insufficiency, it is recommended to start with a small dose and adjust the start, increment, and maximum dose
      according to renal function.


    • Benzbromarone: Benzbromarone inhibits tubular reabsorption of uric acid by inhibiting the renal proximal tubular MSU transporter 1 (URAT-1) to promote uric acid excretion, and patients with mild to moderate renal impairment or eGFR> 60 ml/min do not need to adjust the dose The usual dose is 50mg/d, and the maximum dose is 100mg/d
      .
      It is not recommended for patients with eGFR<30ml/min</b17>
       




    The treatment effect is not good, what is the difficulty?

    There is also some refractory gout, which is a focus of clinical attention, and there is currently no clear definition
    of refractory gout in the world.
    The difficulty is mainly reflected in two aspects, the symptoms of arthritis are difficult to control and uric acid cannot be
    reduced under standard treatment.
    • If the patient does not respond well to the three acute anti-inflammatory drugs, and the joint still repeatedly swells and pains, a combination of the two anti-inflammatory drugs can be considered at this time:

    Choose a full dose of the drug + the preventive dose or half dose of one drug, severe patients can also combine two drugs in full dose, such as NSAIDs combined with colchicine/glucocorticoids, do not advocate the combination of glucocorticoids + NSAIDs, Because it can aggravate adverse reactions
    of the digestive tract.
    • Lowering blood uric acid: urate-lowering treatment needs to meet the standard for a long time, but for a urate-lowering drug titrated to the maximum dose, still can not meet the standard, considering that the patient may not be sensitive to the drug, we first consider to change the drug, if the change of the drug can not meet the standard (4~5 weeks later), then consider the combination of drugs: advocate inhibition of uric acid production drugs combined with drugs
      to promote uric acid excretion.




    Start with your daily diet: keep your mouth shut

    The diet of gout patients has always been a hot topic, the purpose of dietary control is not only to reduce blood uric acid levels and reduce acute attacks of gout, but more importantly, to promote and maintain an ideal health state, prevent and properly manage complications of gout patients, gout patients need to pay attention to the following problems
    in terms of diet.

    Professor Zhu Xiaoxia emphasized that if patients strictly follow the above standards, it will seriously affect their own quality of life, and it is recommended that patients try not to eat "avoidance" and "restricted intake" foods in the acute phase, and when the control of blood uric acid is relatively stable in the intermittent period, it can be eaten appropriately to achieve a balanced
    diet.



    Sport is king

    In the non-acute attack of gouty arthritis, it is necessary to adhere to reasonable exercise
    .
    Exercise helps to prevent gout attacks, but also to strengthen the body, the current recommended exercise methods are:
    1, hyperuricemia patients are recommended to exercise
    regularly.
    2.
    The exercise of gout patients should start from low intensity and gradually transition to medium intensity to avoid strenuous exercise
    .
    Strenuous exercise can increase sweating, reduce blood volume, renal blood flow, reduce uric acid excretion, and even induce gout attacks
    .
    In addition, excessive movement of common joints is also easy to induce recurrence of gout
    .
    In the acute phase of gout, rest is the main thing, interrupting exercise, which is conducive to the resolution of inflammation
    .
    3.
    The number of exercise should be
    4-5 times per week, 0.
    5-1h

    each time.
    Aerobic exercises such as jogging, tai chi, swimming, etc
    .
    can be used.
    4.
    During or after exercise, drink an appropriate amount of water to promote uric acid excretion
    .
    Avoid drinking large amounts of water quickly to avoid burdening
    your body.
    Because low temperature is easy to induce acute attack of gout, cold baths
    should be avoided after exercise.
    5.
    For patients with cardiovascular and pulmonary underlying diseases, exercise intensity and exercise time
    should be moderately reduced.
    Expert profile
    : Zhu Xiaoxia Deputy Chief Physician
    , Department of Rheumatology and Immunology, Huashan Hospital Affiliated to Fudan University


    • Member of Rheumatology Branch of Shanghai Medical Association

    • Member and Secretary of the Youth Committee of the Rheumatology Branch of the Chinese Medical Association

    • Member and Secretary of Gout Group of Rheumatology and Immunology Branch of Chinese Medical Doctor Association

    • Vice Chairman of the Youth Committee of the Immunotherapy Engineering Branch of the Chinese Society of Biomedical Engineering

    • Member and Secretary of the Gout Group of the Rheumatology and Immunology Professional Committee of the Cross-Strait Medical and Health Exchange Association

    • Member and Secretary of the Expert Committee on Hyperuric Acid and Gout of the Chinese Geriatrics Committee

    • From October 2009 to April 2011, he studied abroad at Harvard Medical School

    • Main achievements: He has presided over a number of international, provincial and ministerial projects such as the National Natural Science Foundation of China, the special scientific research fund for doctoral disciplines in colleges and universities of the Ministry of Education, the promotion of appropriate technology of Shanghai Shenkang Development Center, and published a number of SCI and core journal publications







    Where to see more rheumatology clinical knowledge? Come to the "doctor station" and take a look 👇
    at the source of this articleMedical Rheumatology and Immunology ChannelSkin Shrimp This article reviewZhu Xiaoxia Deputy chief physician responsible editorCassette

    Copyright Notice

    This article is original, if you want to reprint, please contact the authorization

    - End - Call for papers

    "Medical Rheumatology and Immunology Channel" long-term recruitment online invited authors, 1.
    Clinical practical skills, misdiagnosed cases, clinical medications, and interesting content of rheumatology and immunology;
    2.
    Interesting diagnosis and treatment stories of rheumatologists and immunologists;
    3.
    Heavy progress in the field of rheumatology and immunology;
    4.
    Others (content of interest to rheumatologists and immunologists is sufficient).


    Welcome to share!

    Click the link below or scan the QR code to submit: https://titan.
    yishengzhan.
    cn/#/public_contribution
    Please fill in the real information
    according to the submission interface
    The medical community strives to be accurate and reliable in the time of review, but does not make any promises and warranties about the timeliness of the published content, the accuracy and completeness of the cited information (if any), etc.
    , nor does it assume any responsibility
    arising from the outdated content or the possible inaccuracy or incompleteness of the cited information.
    Relevant parties are requested to check
    separately when adopting or using this as a basis for decision-making.




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.